Final results of the Minnie Pearl Cancer Research Network first-line trial of weekly paclitaxel/carboplatin/trastuzumab in metastatic breast cancer.

被引:0
|
作者
Yardley, DA
Greco, FA
Hainsworth, JD
Houston, GA
Broome, CM
Bramham, J
Patton, JF
Thompson, DS
Erland, JS
White, MB
Burris, HA
机构
[1] Sarah Cannon Canc Ctr Tennessee Oncol, PLLC, Nashville, TN USA
[2] Jackson Oncol Associates, Jackson, MS USA
[3] No Virginia Oncol Grp PC, Fairfax, VA USA
[4] Graves Gilbert Clin, Bowling Green, KY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
439
引用
收藏
页码:S113 / S113
页数:1
相关论文
共 50 条
  • [41] Vinorelbine and paclitaxel as first-line chemotherapy in metastatic breast cancer
    Acuña, LR
    Langhi, M
    Pérez, J
    Acuña, JR
    Machiavelli, M
    Lacava, J
    Vallejo, C
    Romero, A
    Fasce, H
    Ortiz, E
    Grasso, S
    Amato, S
    Rodríguez, R
    Barbieri, M
    Leone, B
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 74 - 81
  • [42] Final results of a randomized trial on the role of maintenance chemotherapy with weekly paclitaxel for patients with metastatic breast cancer
    Mayordomo, J. I.
    Baena, J. M.
    Cirera, L.
    Sanchez-Rovira, P.
    Godes, M. J.
    Galan, A.
    Jimenez-Orozco, E.
    Munoz, M.
    Tusquets, I.
    Sanchez, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Carboplatin and paclitaxel as first-line treatment of unresectable or metastatic esophageal or gastric cancer
    Prithviraj, G. K.
    Baksh, K.
    Fulp, W.
    Meredith, K.
    Hoffe, S.
    Shridhar, R.
    Almhanna, K.
    DISEASES OF THE ESOPHAGUS, 2015, 28 (08) : 782 - 787
  • [44] Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2+ metastatic breast cancer
    Jahanzeb, M
    Mortimer, JE
    Yunus, F
    Irwin, DH
    Speyer, J
    Koletsky, AJ
    Klein, P
    Sabir, T
    Kronish, L
    ONCOLOGIST, 2002, 7 (05): : 410 - 417
  • [45] Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: A Minnie Pearl Cancer Research Network study
    Greco, FA
    Burris, HA
    Litchy, S
    Barton, JH
    Bradof, JE
    Richards, P
    Scullin, DC
    Erland, JB
    Morrissey, LH
    Hainsworth, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1651 - 1656
  • [46] Successful treatment with weekly paclitaxel and carboplatin combined with trastuzumab in a patient with heavily pretreated metastatic breast cancer
    Kikuchi, Yoshihiro
    Takano, Masashi
    Kudoh, Kazuya
    Kita, Tsunekazu
    Sato, Kazuhiko
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 141 (02) : 189 - 191
  • [47] Nab-Paclitaxel/Bevacizumab/Carboplatin Chemotherapy in First-Line Triple Negative Metastatic Breast Cancer
    Hamilton, Erika
    Kimmick, Gretchen
    Hopkins, Judith
    Marcom, P. Kelly
    Rocha, Gloria
    Welch, Renee
    Broadwater, Gloria
    Blackwell, Kimberly
    CLINICAL BREAST CANCER, 2013, 13 (06) : 416 - 420
  • [48] Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: A Minnie Pearl Cancer Research Network Study
    Hainsworth, John D.
    Spigel, David R.
    Litchy, Sharlene
    Greco, F. Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (22) : 3548 - 3554
  • [49] Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung carcinoma - A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Morrissey, LH
    Scullin, DC
    Houston, GA
    Prasthofer, EF
    Gray, JR
    Burris, HA
    Greco, FA
    CANCER, 2002, 94 (09) : 2426 - 2433
  • [50] Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Burris, HA
    Morrissey, LH
    Thomas, M
    Erland, JB
    Butts, JA
    Joseph, G
    Kalman, L
    Greco, FA
    CANCER JOURNAL, 2000, 6 (03): : 151 - 156